spacer
home > pmps > autumn 2009 > technology tackles counterfeiting
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Technology Tackles Counterfeiting

 

Counterfeiters are more active globally than ever before, feeding on consumer needs for cheaper products, with several distribution channels available to them. Are we doing enough to fight counterfeiting and are we using the right approach? Do we have systems capable of dealing with this issue? A novel technology which uses embedded intelligence in the packaging that cannot be duplicated, thereby creating unique IDs allows for the ultimate fight against counterfeiters. It is time for us to take advantage of this and empower the consumer to verify authenticity.

Drug counterfeiting inhibits growth of legitimate products in the marketplace. In the current global environment, counterfeits are growing significantly to occupy an astounding 10 per cent of the global drug marketplace, according to published reports by the World Health Organization (WHO). The problem is not associated with specific geographic regions, but hits every facet of our global supply chain. If published data on counterfeit vaccines is any indication, things could get even worse if consumers end up using counterfeit H1N1 vaccines and other products. The frightening aspect of all of this is the great reliance on trust alone, because the consumer or brand owner does not have the ability to verify the authenticity of the product any time, anywhere. The life sciences industry is a key target because of its high value products and weak or broken links in the supply chain – essentially the lack of endto- end supply chain visibility. The weak link in the supply chains within countries need to be fixed in order to enhance visibility in the global supply chain.

This article also examines the different options used as security features on packaging, and discusses if we are encouraging the adoption of the best approach with serialised IDs. The article also discusses the embedded, noncopiable intelligence in every package based on its structure, and asks if we would be better off using this as part of any standardised approach, especially as it costs much less than some of the technologies currently used.

STRENGTHENING BUSINESS PROCESSES

A recent study in the EU, Building Radio frequency Identification solutions for the Global Environment (BRIDGE), reported that full supply chain traceability of pharmaceutical products is entirely feasible in an open cross-border supply chain system, when using accepted standards.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Narendra Srivatsa is responsible for Cortegra’s packaging solutions and services for the healthcare industry. He has developed and launched the RxTrackNSecureTM brand to the pharmaceutical industry. Prior to joining Cortegra, he spent 15 years in a number of different key roles at International Paper, leading them into new products and markets. Narendra has been awarded numerous process and product patents, many of which have been commercialised or licensed. He has authored articles in many leading trade publications and has also developed and presented the training module on ‘RFID Enhanced Packaging’ as part of a day long training on ‘RFID in the Life Sciences’ presented at the Interphex 2005 and Interphex 2006.
spacer
Narendra Srivatsa
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>

White Papers

CRSF Label - Child-Resistant Blister Packs With Booklet Label

Faubel & Co. Nachfolger GmbH

This case study explains how Faubel was commissioned by a leading global pharmaceutical company to develop a label for an aluminum blister pack with 14 cavities, which was used as part of a multinational clinical trial. This label was intended to both protect infants from erroneous ingestion and facilitate use by seniors.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement